Shelbourn A, Nuechterlein N, Parada CA, Eaton J, et al. Validating MCM2 as a clinically relevant surrogate immunohistochemical marker for an aggressive meningioma molecular subtype. J Neuropathol Exp Neurol 2023 Oct 13:nlad082. doi: 10.1093.
PMID: 37837323